| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |